Get the app
US › Healthcare

Artelo Biosciences Inc (ARTL)

US · Healthcare · Biotechnology

$3.97+5.87%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-2.4M
EPS
$-0.89

Key statistics

Market cap
$3.0M
Forward P/E
0.0
P/B
0.59
Book value
$10.74
EPS (TTM)
$-101.07
52-week high
$166.32
52-week low
$4.68
50-day MA
$7.56
200-day MA
$28.88
Beta
-0.07

Analyst view

Analysts rate Artelo Biosciences Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $18.00.

Shareholding

Insiders
0.11%
Institutions
2.38%

Largest institutional holders

FundStake
Jane Street Group LLC0.27%
Vanguard Capital Management, LLC0.21%
Vanguard Fiduciary Trust Co0.06%
Citigroup Inc0.06%
Tower Research Capital LLC0.06%
Clear Street Group Inc0.00%
Rothschild Wealth Partners0.00%
Danske Bank A/S.0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Artelo Biosciences Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.